ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1234 participants.

Also called NCT05172960

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,234 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05172960
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Australia, Canada, New Zealand (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05172960. Non-randomized; no masking; primary purpose treatment. Start 2022-06-20 (actual); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
Condition
Aortic Stenosis, Severe
Intervention (Device)
SAPIEN X4 THV
Intervention (Device)
SAPIEN X4S
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct05172960
Content hash
f1ca350104882538da210640f0a9577e478b969a3cd5a7e0738decd330abba14